Ovine cortical osteoblasts outperform bone marrow cells in an ectopic bone assay

Area of Science:

• Regenerative Medicine
• Biomaterials Science
• Orthopedic Research

Background:

• Marrow-derived mesenchymal stem cells (BMSCs) are widely considered the standard for bone tissue engineering due to differentiation potential and accessibility.
• Limited comparative studies exist on the osteogenic performance of BMSCs versus bone-derived osteoblasts (OBs).

Purpose of the Study:

• To compare the osteogenic potential of ovine BMSCs and OBs in vivo.
• To evaluate the effect of recombinant human bone morphogenetic protein 7 (rhBMP-7) on bone formation and vascularization.
• To determine the influence of cell origin and growth factors on ossification characteristics.

Main Methods:

• Ovine BMSCs and OBs were seeded onto scaffolds and transplanted subcutaneously into NOD/SCID mice.
• Specimens were analyzed with biomechanical testing, micro-CT, SEM/EDX, and immunohistochemistry.
• The impact of rhBMP-7 stimulation was assessed.

Main Results:

• Both BMSCs and OBs exhibited high survival and proliferation, contributing to ectopic endochondral osteogenesis.
• OBs demonstrated significantly higher bone deposition and maturation compared to BMSCs.
• rhBMP-7 enhanced bone synthesis, promoted neovascularization, and increased osteoclast activity for both cell types.

Conclusions:

• Cell origin and commitment critically influence the type and degree of ossification in bone tissue engineering.
• rhBMP-7 is a potent adjuvant for enhancing bone regeneration and vascularization.
• Mature bone-derived osteoblasts are a viable alternative cell source for bone tissue engineering applications.